In extended research, maternal serum analytes used in the first- and second-trimester screening tests, such as PAPP-A and βhCG, have been found to be related to poor pregnancy outcomes, such as preterm labor, preeclampsia, antenatal bleeding, gestational diabetes, low birth weight, stillbirth, and fetal loss [5,7]. Here, PAPPA is linked to gestational diabetes.